Myogenic differentiation of p53- and Rb-deficient immortalized and transformed bovine fibroblasts in response to MyoD

Molecules and Cells

Volumn 21, Issue 2, 2006, Pages 206-212

  Jin, Xun ^a,b   Lee, Joong Seub ^a   Kwak, Sungwook ^a,b   Jung, Ji Eun ^a   Kim, Tae Kyung ^a   Xu, Chenxiong ^b   Hong, Zhongshan ^b   Li, Zhehu ^b   Kim, Sun Myoung ^b   Whang, Kwang Youn ^a   Hong, Ki Chang ^a   You, Seungkwon ^a   Choi, Yun Jaie ^b   Kim, Hyunggee ^a  

^a Korea University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

BEF; Muscle differentiation; MyoD; p53; Rb; SV40LT

Indexed keywords

DESMIN; INSULIN; MYOD PROTEIN; PROTEIN P16INK4A; PROTEIN P53; RETINOBLASTOMA PROTEIN;

AGAR MEDIUM; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL STRUCTURE; CELL TRANSFORMATION; CELL TYPE; CONTROLLED STUDY; EMBRYO; EMBRYO CELL; FIBROBLAST; GENE OVEREXPRESSION; IMMUNOFLUORESCENCE; LIFESPAN; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; NONHUMAN; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; WESTERN BLOTTING;

ANIMALS; CATTLE; CELL DIFFERENTIATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FIBROBLASTS; MUSCLE DEVELOPMENT; MYOD PROTEIN; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; BOVINAE; EQUUS CABALLUS;

EID: 33646537129     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Armant, D. R. (2005) Blastocysts don't go it alone. Extrinsic signals fine-tune the intrinsic developmental program of trophoblast cells. Dev. Biol. 280, 260-280.
2. Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C. P., et al. (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352.
3. Braun, T., Bober, E., Buschhausen-Denker, G., Kohtz, S., Grzeschik, K. H., et al. (1989) Differential expression of myogenic determination genes in muscle cells: possible auto-activation by the Myf gene products. EMBO J. 8, 3617-3625.
4. Davis, R. L., Weintraub, H., and Lassar, A. B. (1987) Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51, 987-1000.
5. De, S. R., Zahra, D. G., Duncan, E. L., and Reddel, R. R. (1995) Immortalization of human fibroblasts by liposome-mediated transfer of SV40 early region genes. Methods Cell Sci. 17, 75-81.
6. Dias, P., Parham, D. M., Shapiro, D. N., Tapscott, S. J., and Houghton, P. J. (1992) Monoclonal antibodies to the myogenic regulatory protein MyoD1: epitope mapping and diagnostic utility. Cancer Res. 52, 6431-6439.
7. Felix, C. A., Kappel, C. C., Mitsudomi, T., Nau, M. M., Tsokos, M., et al. (1992) Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma. Cancer Res. 52, 2243-2247.
8. Frolov, M. V. and Dyson, N. J. (2004) Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J. Cell Sci. 117, 2173-2181.
9. Hahn, W. C. (2002) Immortalization and Transformation of Human Cells. Mol. Cells 13, 351-361.
10. Hammond, E. M. and Giaccia, A. J. (2005) The role of p53 in hypoxia-induced apoptosis, Biochem. Biophys. Res. Commun. 331, 718-725.
11. Hayflick, L. and Moorhead, P. S. (1961) The serial cultivation of human diploid cell strains. Exp. Cell Res. 25, 585-621.
12. Jha, K. K., Banga, S., Palejwala, V., and Ozer, H. L. (1998) SV40-mediated immortalization. Exp. Cell Res. 245, 1-7.
13. Keller, C., Arenkiel, B. R., Coffin, C. M., El-Bardeesy, N., DePinho, R. A., et al. (2004) Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function. Genes Dev. 18, 2614-2626.
14. Kim, H., Farris, J., Christman, S. A., Kong, B. W., Foster, L. K., et al. (2002a) Events in the immortalizing process of primary human mammary epithelial cells by the catalytic subunit of human telomerase. Biochem. J. 365, 765-772.
15. Kim, H., You, S., Farris, J., Kong, B. W., Christman, S. A., et al. (2002b) Expression profiles of p53, p16INK4a and telomere regulating genes in the replicative senescent human, mouse and chicken fibroblast cells. Exp. Cell Res. 272, 199-208.
16. Ko, L. J. and Prives, C. (1996) p53: puzzle and paradigm. Genes Dev. 10, 1054-1072.
17. Lee, S. M., Youn, B. H., Kim, C. S., Kim C. S., Kang, C. H., et al. (2005) Gamma-Irradiation and doxorubicin treatment of normal human cells cause cell cycle arrest via different pathways. Mol. Cells 20, 331-338.
18. Levine, A. J. (1997) p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
19. Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., et al. (1995) Retinoblastomaprotein-dependent cell-cycle inhibition by the tumor suppressor p16. Nature 375, 503-506.
20. Noble, J. R., Zhong, Z. H., Neumann, A. A., Melki, J. R., Clark, S. J., et al. (2004) Alterations in the p16(INK4a) and p53 tumor suppressor genes of hTERT-immortalized human fibroblasts. Oncogene 23, 3116-3121.
21. ARF, or p53 and is accelerated by inactivation of Bax. BMC Cell Biol. 5, 1-14.
22. Porrello, A., Cerone, M. A., Coen, S., Gurtner, A., Fontemaggi, G., et al. (2000) p53 regulates myogenesis by triggering the differentiation activity of pRb. J. Cell Biol. 151, 1295-1304.
23. Puri, P. L., Bhakta, K., Wood, L. D., Costanzo, A., Zhu, J., et al. (2002) A myogenic differentiation checkpoint activated by genotoxic stress. Nat. Genet. 32, 585-593.
24. Richler, C. and Yaffe, D. (1970) The in vitro cultivation and differentiation capacities of myogenic cell lines. Dev. Biol. 23, 1-22.
25. Rothenberg, E. V. and Taghon, T. (2005) Molecular genetics of T cell development. Annu. Rev. Immunol. 23, 601-649.
26. Sherr, C. J. and DePinho, R. A. (2000) Cellular senescence: mitotic clock or culture shock? Cell 102, 407-410.
27. Shieh, S.-Y., Ikeda, M., Taya, Y., and Prives, C. (1997) DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91, 325-334.
28. Takahashi, Y., Oda, Y., Kawaguchi, K., Tamiya, S., Yamamoto, H., et al. (2004) Altered expression and molecular abnormalities of cell-cycle-regulatory proteins in rhabdomyosarcoma. Mod. Pathol. 17, 660-669.
29. Tapscott, S. J., Thayer, M., and Weintraub, H. (1993) Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis. Science 259, 1450-1453.
30. Taylor, L. M., James, A., Schuller, C. E., Brce, J., Lock, R. B., et al. (2004) Inactivation of p16INK4a, with retention of pRB and p53/p21cipl function, in human MRC5 fibroblasts that overcome a telomere-independent crisis during immortalization. J. Biol. Chem. 279, 43634-43645.
31. Weintraub, H., Tapscott, S. J., Davis, R. L., Thayer, M. J., Adam, M. A., et al. (1989) Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc. Natl. Acad. Sci. USA 86, 5434-5438.
32. White, J. D., Rachel, C., Vermeulen, R., Davies, M., and Grounds, M. D. (2002) The role of p53 in vivo during skeletal muscle post-natal development and regeneration: studies in p53 knockout mice. Int. J. Dev. Biol. 46, 577-582.
33. Wright, W. E., Sassoon, D. A., and Lin, V. K. (1989) Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell 56, 607-617.
34. Yaffe, D. (1968) Retention of differentiation potentialities during prolonged cultivation of myogenic cells. Proc. Natl. Acad. Sci. USA 61, 477-483.
35. Yeager, T. R. and Reddel, R. R. (1999) Constructing immortalized human cell lines. Curr. Opin. Biotechnol. 10, 465-469.
36. You, S., Moon, J. H., Kim, T. K., Kim, S. C., Kim, J. W., et al. (2004) Cellular characteristics of primary and immortal canine embryonic fibroblast cells. Exp. Mol. Med. 36, 325-335.